PT - JOURNAL ARTICLE AU - E. R. Cirilo AU - P. L. Natti AU - N. M. L. Romeiro AU - M.A.C. Candezano AU - J. M. P. Polo TI - One Study of COVID-19 Spreading at The United States - Brazil - Colombia<sup>1</sup> AID - 10.1101/2020.08.29.20184465 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.29.20184465 4099 - http://medrxiv.org/content/early/2020/09/02/2020.08.29.20184465.short 4100 - http://medrxiv.org/content/early/2020/09/02/2020.08.29.20184465.full AB - The present work concerns the COVID-19’s spread over The United States, Brazil and Colombia. Although countries show differences in economic development, but similarities such as continental dimension or social interaction, the spread of COVID-19 in them has some similarities. At the moment, the countries are living the disease with temporal delay. Thus, we used a database on WHO Coronavirus, Mathematical Modeling and Numerical Simulations to describe the most recent COVID-19 development patterns in these countries, which we saw.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Universidade Estadual de Londrina-BR. Also, by support of the Centro de Modelacion Matem&amp;aacutetica y Computacion Cient&amp;iacutefica of the Universidad del Atlantico.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Without restriction.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available from ercirilo{at}uel.br.